Portfolio company
Ravada Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence and hardware to transform MRI scanners into non-invasive pathology platforms for biopsy-saving prostate cancer diagnostics.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PCaVision
This company develops artificial intelligence software that analyses ultrasound recordings to assist urologists with prostate cancer diagnosis and biopsy planning for clinical patients.
Refined Diagnostics
This company develops AI-powered laser imaging systems for real-time, stain-free tissue analysis and cancer diagnostics for surgeons, pathologists, and hospitals.
RADiCAIT
This company develops artificial intelligence software that converts standard CT scans into functional PET-like images for radiologists and oncologists.
Waiv
This company develops artificial intelligence diagnostic tests and digital pathology software for oncology laboratories and healthcare providers to improve cancer patient treatment decisions.
Medical Imaging
This company develops artificial intelligence-powered medical imaging devices and reconstruction software to enhance diagnostic scan quality and efficiency for clinicians and healthcare providers.
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Exact Imaging
This company develops high-resolution micro-ultrasound systems for urologists to perform real-time imaging and guided biopsies for prostate cancer detection.
Neurolase
This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.
